Efficacy of a food plant-based oral cholera toxin B subunit vaccine

Nature Biotechnology
T ArakawaW H Langridge

Abstract

Transgenic potatoes were engineered to synthesize a cholera toxin B subunit (CTB) pentamer with affinity for GMI-ganglioside. Both serum and intestinal CTB-specific antibodies were induced in orally immunized mice. Mucosal antibody titers declined gradually after the last immunization but were restored following an oral booster of transgenic potato. The cytopathic effect of cholera holotoxin (CT) on Vero cells was neutralized by serum from mice immunized with transgenic potato tissues. Following intraileal injection with CT, the plant-immunized mice showed up to a 60% reduction in diarrheal fluid accumulation in the small intestine. Protection against CT was based on inhibition of enterotoxin binding to the cell-surface receptor GMI-ganglioside. These results demonstrate the ability of transgenic food plants to generate protective immunity in mice against a bacterial enterotoxin.

References

Jan 1, 1979·Transactions of the Royal Society of Tropical Medicine and Hygiene·M M LevineJ P Libonati
Jan 1, 1976·Advances in Experimental Medicine and Biology·L Svennerholm
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A EscherA A Szalay
Jan 1, 1989·International Archives of Allergy and Applied Immunology·N LyckeJ Holmgren
Oct 1, 1971·Infection and Immunity·K Punyashthiti, R A Finkelstein
Jun 1, 1972·The Journal of Infectious Diseases·K Fujita, R A Finkelstein
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·J B SunC Czerkinsky
Sep 1, 1995·Trends in Biotechnology·H S Mason, C J Arntzen
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·Y ThanavalaC Arntzen
Sep 2, 1994·Science·J J Mekalanos, J C Sadoff
Feb 1, 1993·Infection and Immunity·M T Dertzbaugh, C O Elson
May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·H S MasonC J Arntzen
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·J B SunC Czerkinsky
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·I BergerotC Thivolet
Jan 10, 1998·Transgenic Research·T ArakawaW H Langridge
Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·C KonczA A Szalay
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W H LangridgeA A Szalay

❮ Previous
Next ❯

Citations

Feb 19, 2010·Archivum Immunologiae Et Therapiae Experimentalis·Józef KapustaAndrzej Płucienniczak
Mar 1, 2013·Applied Microbiology and Biotechnology·Zheng-jun GuanYa-hui Wei
Aug 17, 2006·Biotechnology Letters·Qing GuMuyuan Zhu
Nov 30, 2000·Current Infectious Disease Reports·J Yu, W H Langridge
Jun 10, 2009·Molecular Biotechnology·Eun-Ah ShinJin-Yong Lee
Jun 5, 2003·International Journal for Parasitology·Stephen J Streatfield, John A Howard
Oct 28, 1998·Molecular Aspects of Medicine·G Del GiudiceR Rappuoli
Jul 14, 2001·Trends in Biotechnology·E J RyanK H Mills
Sep 23, 2000·Journal of Biotechnology·M E Baca-EstradaL A Babiuk
Sep 23, 2000·Journal of Biotechnology·L A Babiuk, S K Tikoo
May 29, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·H Chen
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·G J Russell-Jones
Mar 21, 2001·Vaccine·S J StreatfieldJ A Howard
Jul 25, 2003·Veterinary Parasitology·M W LightowlersC Sato
Apr 13, 1999·Infectious Disease Clinics of North America·J D Gradon, L I Lutwick
Dec 3, 1998·Research in Immunology·J W LarrickK Wycoff
Feb 7, 2001·Current Opinion in Biotechnology·A M Walmsley, C J Arntzen
Sep 12, 2001·Current Opinion in Biotechnology·J W Larrick, D W Thomas
Oct 18, 2001·Current Opinion in Biotechnology·G Giddings
Oct 18, 2001·Current Opinion in Biotechnology·A MercenierH Breiteneder
Apr 21, 1999·Current Opinion in Biotechnology·K Herbers, U Sonnewald
Aug 17, 1999·Current Opinion in Biotechnology·E E Hood, J M Jilka
Dec 10, 1998·Trends in Microbiology·T S MorK E Palmer
May 18, 2000·Microbes and Infection·C O Tacket, H S Mason
Sep 22, 2001·Biomolecular Engineering·J W LarrickK Wycoff
Jul 13, 2002·Trends in Molecular Medicine·Hugh S MasonCharles J Arntzen
May 19, 1998·Nature Medicine·T Arakawa, W H Langridge
May 19, 1998·Nature Medicine·M A Liu
Apr 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Daisuke TokuharaHiroshi Kiyono

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Hugh S MasonC J Arntzen
Proceedings of the National Academy of Sciences of the United States of America
Y ThanavalaC J Arntzen
Proceedings of the National Academy of Sciences of the United States of America
Hugh S MasonC J Arntzen
© 2022 Meta ULC. All rights reserved